Stay updated on Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.

Latest updates to the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice plus Revision: v3.4.1; these updates are administrative and do not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedNotice about government funding affecting site operations is shown. The page now lists Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedThe changes are cosmetic metadata updates (glossary toggle, Last Update Submitted that Met QC Criteria, No FEAR Act labeling, and Revision: v3.4.0) that do not affect core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedNew document revision v3.3.4 replaces v3.3.3, a minor metadata update with no change to core study content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page adds a Locations section showing three study sites (Duarte, CA; Aurora, CO; Philadelphia, PA) and their institutions, and displays a Revision: v3.3.3 tag.SummaryDifference0.4%

- Check92 days agoChange DetectedThe page revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Chemo in Peripheral T Cell Lymphomas Clinical Trial page.